Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-035143
Filing Date
2020-06-08
Accepted
2020-06-08 20:10:34
Documents
1
Period of Report
2020-06-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4064
  Complete submission text file 0001209191-20-035143.txt   5504
Mailing Address 201 SPEAR STREET, 3RD FLOOR SAN FRANCISCO CA 94107
Business Address
Machado Patrick (Reporting) CIK: 0001311210 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38653 | Film No.: 20950631

Mailing Address 220 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 220 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 416-7700
Principia Biopharma Inc. (Issuer) CIK: 0001510487 (see all company filings)

IRS No.: 263487603 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations